DeepMed Research

Alk-Abelló A/S

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: -

Established: 1923-01-01

Employees: -

Market Cap: $5.8B

Website: http://www.alk.net/

Clinical Trials

Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis

Conditions: Allergic Rhinitis Due to House Dust Mite
Allergic Asthma

Interventions: Drug: Standardised allergen extract from house dust mites

First Posted Date: 2023-11-30

Last Posted Date: 2024-03-20

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 100

Registration Number: NCT06151938

Locations: 🇨🇳
Ruijin-Hainan Hospital Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Qionghai, Hainan, China

The Effect of Allergic Rhinitis on Educational Outcomes

Recruiting

Conditions: Allergic Rhinitis

Interventions: Other: Observational

First Posted Date: 2023-05-31

Last Posted Date: 2023-05-31

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 150000

Registration Number: NCT05881577

Locations: 🇩🇰
ALK Abello, Hørsholm, Hovedstaden, Denmark

Observational Study of Allergic Rhinitis in Children

Recruiting

Conditions: Allergic Rhinitis

First Posted Date: 2022-12-19

Last Posted Date: 2022-12-19

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 1000

Registration Number: NCT05655858

Locations: 🇫🇷
Hôpital Necker-Enfants malades - AP-HP Service de Pneumologie et Allergologie Pédiatriques, Paris, France

Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma

Active, not recruiting

Conditions: Asthma
Allergic Rhinitis
Allergy

Interventions: Drug: SQ SLIT-tablet

First Posted Date: 2022-07-27

Last Posted Date: 2023-08-02

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 49844

Registration Number: NCT05476484

Locations: 🇩🇰
ALK, Hørsholm, Copenhagen, Denmark

Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Phase 1

Recruiting

Conditions: Peanut Allergy

Interventions: Biological: Peanut SLIT-tablet
Other: Placebo

First Posted Date: 2022-07-01

Last Posted Date: 2025-05-14

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 192

Registration Number: NCT05440643

Locations: 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸
Children's Hospital of Los Angeles - USC School of Medicine, Los Angeles, California, United States
🇺🇸
UCLA - Pediatrics, Los Angeles, California, United States

and more 38 locations

A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

Phase 3

Completed

Conditions: Allergy

Interventions: Drug: Placebo
Drug: 5-grass mix SLIT-drops

First Posted Date: 2021-05-11

Last Posted Date: 2024-12-16

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 445

Registration Number: NCT04881461

Locations: 🇵🇱
Grażyna Pulka Centrum Medyczne ALL-MED, Kraków, Malopolskie, Poland
🇵🇱
Snzoz Alergologia Plus Ośrodek Diagnostyki i Terapii Uczuleń, Poznań, Wielkopolskie, Poland
🇱🇹
Allergy Clinic JSC Perspektyvos, Vilnius, Lithuania

and more 41 locations

A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis

Phase 3

Completed

Conditions: Allergy

Interventions: Drug: Placebo SLIT-tablet
Drug: Tree SLIT-tablet

First Posted Date: 2021-05-07

Last Posted Date: 2025-01-22

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 952

Registration Number: NCT04878354

Locations: 🇭🇺
Aranyklinika Kft, Szeged, Csongrád, Hungary
🇱🇹
"Inlita" JSC Santara CTC, Vilnius, Vilniaus Apskritis, Lithuania
🇦🇹
Medical University of Vienna, Vienna, Austria

and more 76 locations

Adolescent Mite Allergy Safety Evaluation

Phase 3

Completed

Conditions: Allergic Rhinitis
Allergic Rhinoconjunctivitis

Interventions: Biological: HDM SLIT-tablet

First Posted Date: 2020-09-09

Last Posted Date: 2023-07-03

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 253

Registration Number: NCT04541004

Locations: 🇸🇰
NZZ Imunologicka ambulancia, Poprad, Slovakia
🇨🇿
Alergopraktik s.r.o., Jablonec Nad Nisou, Czechia
🇸🇰
Medimun s.r.o., Trnava, Slovakia

and more 24 locations

A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber

Phase 3

Terminated

Conditions: Allergic Rhinoconjunctivitis

Interventions: Other: Placebo
Biological: Sublingual allergy immunological tablet

First Posted Date: 2019-11-25

Last Posted Date: 2022-06-30

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 80

Registration Number: NCT04176185

Locations: 🇨🇳
Tongren Hospital, Beijing, China
🇦🇹
Vienna Challenge Chamber, Vienna, Austria

House Dust Mite Allergy Trial In Children

Phase 3

Completed

Conditions: Allergic Rhinitis Due to House Dust Mite
Allergic Rhinitis Due to Dermatophagoides Farinae
Allergic Rhinitis Due to Dermatophagoides Pteronyssinus

Interventions: Biological: Sublingual allergy immunotherapy tablet
Other: Placebo

First Posted Date: 2019-10-30

Last Posted Date: 2024-06-12

Lead Sponsor: ALK-Abelló A/S

Target Recruit Count: 1460

Registration Number: NCT04145219

Locations: 🇺🇸
California Allergy and Asthma Medical Group, Los Angeles, California, United States
🇺🇸
Deaconess Clinic Allergy, Evansville, Indiana, United States
🇧🇬
Multiprofile Hospital for active treatment, Department of Pediatrics, Gabrovo, Bulgaria

and more 107 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy